SEC Comment Letter 0000000000-24-001523 to Fulgent Genetics, Inc. (FLGT) (CIK 0001674930) (FLGT)
Fulgent Genetics, Inc. (FLGT) (CIK 0001674930)
Date: Feb. 8, 2024 · CIK: 0001674930 · Accession: 0000000000-24-001523
AI Filing Summary & Sentiment
File numbers found in text: 001-37894
Letter
United States securities and exchange commission logo February 8, 2024 Paul Kim Chief Financial Officer Fulgent Genetics, Inc. 4399 Santa Anita Avenue El Monte, California 91731 Re:Fulgent Genetics, Inc. Form 10-K for Fiscal Year Ended December 31, 2022 File No. 001-37894 Dear Paul Kim: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services
Show Raw Text
United States securities and exchange commission logo
February 8, 2024
Paul Kim
Chief Financial Officer
Fulgent Genetics, Inc.
4399 Santa Anita Avenue
El Monte, California 91731
Re:Fulgent Genetics, Inc.
Form 10-K for Fiscal Year Ended December 31, 2022
File No. 001-37894
Dear Paul Kim:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services